Fujifilm shares fall after report Avigan not showing clear efficacy in some coronavirus trials

TOKYO (Reuters) - Shares of Fujifilm Holdings Corp fell on Wednesday after Kyodo news agency reported that so far there has been no clear evidence of efficacy for its drug Avigan in treating the novel coronavirus in some clinical trials.The data reported to Japan's health ministry by hospitals treating people showing mild or no symptoms raises doubts about whether the drug can be approved by the end of this month as sought by Japan's government, the report said, citing unidentified..